Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 143

1.

Monoclonal antibody-based therapy for neuroblastoma.

Cheung NK.

Curr Oncol Rep. 2000 Nov;2(6):547-53. Review.

PMID:
11122891
[PubMed - indexed for MEDLINE]
2.

Induction of Ab3 and Ab3' antibody was associated with long-term survival after anti-G(D2) antibody therapy of stage 4 neuroblastoma.

Cheung NK, Guo HF, Heller G, Cheung IY.

Clin Cancer Res. 2000 Jul;6(7):2653-60.

PMID:
10914706
[PubMed - indexed for MEDLINE]
Free Article
3.

Targeted interleukin-2 therapy for spontaneous neuroblastoma metastases to bone marrow.

Lode HN, Xiang R, Varki NM, Dolman CS, Gillies SD, Reisfeld RA.

J Natl Cancer Inst. 1997 Nov 5;89(21):1586-94.

PMID:
9362156
[PubMed - indexed for MEDLINE]
Free Article
4.

Disialoganglioside directed immunotherapy of neuroblastoma.

Modak S, Cheung NK.

Cancer Invest. 2007 Feb;25(1):67-77. Review.

PMID:
17364560
[PubMed - indexed for MEDLINE]
5.

Immunotherapy. Neuroblastoma as a model.

Cheung NK.

Pediatr Clin North Am. 1991 Apr;38(2):425-41. Review.

PMID:
2006085
[PubMed - indexed for MEDLINE]
6.

Molecularly guided therapy of neuroblastoma: a review of different approaches.

Tonini GP, Pistoia V.

Curr Pharm Des. 2006;12(18):2303-17. Review.

PMID:
16787256
[PubMed - indexed for MEDLINE]
7.

Role of autotransplantation in neuroblastoma.

Johnson FL, Goldman S.

Hematol Oncol Clin North Am. 1993 Jun;7(3):647-62. Review.

PMID:
8344884
[PubMed - indexed for MEDLINE]
8.

Cytokine, chemokine, and co-stimulatory fusion proteins for the immunotherapy of solid tumors.

Khawli LA, Hu P, Epstein AL.

Handb Exp Pharmacol. 2008;(181):291-328. Review.

PMID:
18071951
[PubMed - indexed for MEDLINE]
9.

S-L 11.14: a monoclonal antibody recognizing neuroectodermal tumors with possible value for bone marrow purging before autograft.

Combaret V, Kremens B, Favrot MC, Laurent JC, Philip T.

Bone Marrow Transplant. 1988 May;3(3):221-7.

PMID:
2844344
[PubMed - indexed for MEDLINE]
10.

Disaloganglioside GD2 loss following monoclonal antibody therapy is rare in neuroblastoma.

Kramer K, Gerald WL, Kushner BH, Larson SM, Hameed M, Cheung NK.

Med Pediatr Oncol. 2001 Jan;36(1):194-6.

PMID:
11464881
[PubMed - indexed for MEDLINE]
11.

Contemporary therapeutic options for children with high risk neuroblastoma.

Sterba J.

Neoplasma. 2002;49(3):133-40. Review.

PMID:
12097996
[PubMed - indexed for MEDLINE]
12.

Neuroblastoma: Therapeutic strategies for a clinical enigma.

Modak S, Cheung NK.

Cancer Treat Rev. 2010 Jun;36(4):307-17. doi: 10.1016/j.ctrv.2010.02.006. Epub 2010 Mar 12. Review.

PMID:
20227189
[PubMed - indexed for MEDLINE]
13.

Early molecular response of marrow disease to biologic therapy is highly prognostic in neuroblastoma.

Cheung IY, Lo Piccolo MS, Kushner BH, Cheung NK.

J Clin Oncol. 2003 Oct 15;21(20):3853-8.

PMID:
14551304
[PubMed - indexed for MEDLINE]
14.

Antibody-based immunotherapy in high-risk neuroblastoma.

Johnson E, Dean SM, Sondel PM.

Expert Rev Mol Med. 2007 Dec 17;9(34):1-21. Review.

PMID:
18081947
[PubMed - indexed for MEDLINE]
15.

Autologous bone marrow transplantation with negative immunomagnetic purging for aggressive B-cell non-Hodgkin's lymphoma in first complete remission.

De Rosa L, Lalle M, Pandolfi A, Ruscio C, Amodeo R.

Ann Hematol. 2002 Oct;81(10):575-81. Epub 2002 Sep 24.

PMID:
12424539
[PubMed - indexed for MEDLINE]
16.

Detection of minimal disease in bone marrow of neuroblastoma patients by immunofluorescence.

Berthold F, Schneider A, Schumacher R, Bosslet K.

Pediatr Hematol Oncol. 1989;6(2):73-83.

PMID:
2702075
[PubMed - indexed for MEDLINE]
17.

Monoclonal antibody-based therapy of neuroblastoma.

Cheung NK, Kushner BH, Kramer K.

Hematol Oncol Clin North Am. 2001 Oct;15(5):853-66. Review.

PMID:
11765377
[PubMed - indexed for MEDLINE]
18.

Overview of resistance to systemic therapy in patients with breast cancer.

Gonzalez-Angulo AM, Morales-Vasquez F, Hortobagyi GN.

Adv Exp Med Biol. 2007;608:1-22. Review.

PMID:
17993229
[PubMed - indexed for MEDLINE]
19.

High-dose cyclophosphamide inhibition of humoral immune response to murine monoclonal antibody 3F8 in neuroblastoma patients: broad implications for immunotherapy.

Kushner BH, Cheung IY, Kramer K, Modak S, Cheung NK.

Pediatr Blood Cancer. 2007 Apr;48(4):430-4.

PMID:
16421906
[PubMed - indexed for MEDLINE]
20.

Quantitation of tumor cell removal from bone marrow: a preclinical model.

Moss TJ, Xu ZJ, Mansour VH, Hardwick A, Kulcinski D, Ishizawa L, Law P, Gee A.

J Hematother. 1992 Spring;1(1):65-73.

PMID:
1365018
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk